Cell Surface Modification by Activated Polyethylene Glycol Prevents Allosensitization after Islet Transplantation

• Published in: Cell transplantation 2008-01, Vol.17 (10-11), p.1257-1269
• Main Authors: Wee, Yu-Mee, Lim, Dong-Gyun, Kim, Yang-Hee, Kim, Jin-Hee, Kim, Song-Cheol, Yu, Eunsil, Park, Myung-Ok, Choi, Monica Young, Park, Youn-Hee, Jang, Hyuk-Jai, Cho, Eun-Young, Cho, Myung-Hwan, Han, Duck-Jong
• Format: Article
• Language: English
• Subjects: Animals; Antigens, Surface - drug effects; Antigens, Surface - immunology; Cell Survival - drug effects; Cells, Cultured; Cross-Linking Reagents - pharmacology; Diabetes Mellitus, Experimental - immunology; Diabetes Mellitus, Experimental - therapy; Graft Rejection - prevention & control; Immunosuppression - methods; Islets of Langerhans - drug effects; Islets of Langerhans - immunology; Islets of Langerhans - physiology; Islets of Langerhans Transplantation - immunology; Islets of Langerhans Transplantation - methods; Polyethylene Glycols - pharmacology; Rats; Rats, Inbred F344; Rats, Inbred Lew; Streptozocin; Surface Properties - drug effects; Transplantation Tolerance - drug effects; Triazines - pharmacology
• ISSN: 0963-6897; 1555-3892
• DOI: 10.3727/096368908787236657

The necessity to transplant islet tissue without the need for immunosuppressant therapy has led to the development of materials for immune modulation. Pegylation makes islets antigenically silent, protecting them from the adsorption of foreign protein and thus avoiding immune injury. The aim of this study is to determine whether pegylation of islets prolongs islet survival and function both during tissue culture and posttransplantation. We used cyanuric chloride-activated methoxy-polyethylene glycol for cell surface modification. To detect the pegylation effect on splenocytes, we measured antibody binding inhibition and abrogation of lymphocyte proliferation. To detect the pegylation effect on islet grafts, we performed rodent islet transplantation. Islet viability and function were maintained after pegylation. Pegylated islets showed a 90% decrease in antibody binding and decreased lymphocyte proliferation in a mixed lymphocyte culture. However, when pegylated islets were transplanted, no prolongation of graft survival was observed. When a subtherapeutic dose of immunosuppressant was given at the time of transplantation of pegylated islets, islet graft survival was significantly prolonged. In addition, when rats were sensitized with donor splenocytes, graft survival was prolonged by pegylation. We observed that pegylation of islets, combined with a subtherapeutic dose of immunosuppressant, protects the graft from rejection. Prolonged graft survival in sensitized recipients showed that pegylation of islets shifted the pattern of rejection from an acute humoral response to a less aggressive cellular alloresponse.